Recent achievements of the National Center Biobank Network (NCBN) bioresources through Japanese fiscal year 2025.
- 1Central Biobank, National Center Biobank Network (NCBN), Tokyo, Japan.
- 2Genome Medical Science Project, National Institute of Global Health and Medicine (NIGHM), Japan Institute for Health Security (JIHS), Tokyo, Japan.
Abstract
The National Center Biobank Network (NCBN) is constituted by a network of biobanks from five National Centers and the Japan Institute for Health Security (JIHS). The NCBN primarily collects samples from patients with various diseases, amassing a total of more than 250,000 participants and 800,000 human biospecimens as of the end of March 2026. The primary sample types are blood and DNA, with spinal fluid and frozen tissue samples also collected depending on the characteristics of the disease. These samples are accompanied by highly specialized and traceable clinical information supported by advanced medical care and expertise. Moreover, some samples are accompanied by whole-genome sequencing data. Consequently, these resources provide a unique platform for translational research, biomarker discovery, and genomic medicine in Japan. In the present review, we provide a detailed account of the recent achievements of NCBN biobanks and their biospecimens and genomic data.
Related
- Parliamentary workload and outpatient medical costs among Japanese national civil servants: An ecological study in Kasumigaseki
- Experience and Operation of Establishing the Korea Biobank Network for Inflammatory Bowel Disease and Colorectal Cancer
- Drug repurposing: Landmark achievements in translational medicine
- Oral Health Birth Cohort Studies: Achievements, Challenges, and Potential
- Nicotine replacement therapy sampling for cigarette cessation in dental care: A National Dental Practice-Based Research Network cluster randomized clinical trial
BibTeX
@article{omae2026recent,
title = {{Recent achievements of the National Center Biobank Network (NCBN) bioresources through Japanese fiscal year 2025.}},
author = {Yosuke Omae and Katsushi Tokunaga},
journal = {Frontiers in genetics},
year = {2026},
month = oct,
doi = {10.3389/fgene.2026.1910504},
url = {https://europepmc.org/article/MED/42968993},
note = {CC BY},
}
RIS
TY - JOUR
TI - Recent achievements of the National Center Biobank Network (NCBN) bioresources through Japanese fiscal year 2025.
AU - Yosuke Omae
AU - Katsushi Tokunaga
PY - 2026
DA - 2026/10/19
JO - Frontiers in genetics
DO - 10.3389/fgene.2026.1910504
UR - https://europepmc.org/article/MED/42968993
AB - The National Center Biobank Network (NCBN) is constituted by a network of biobanks from five National Centers and the Japan Institute for Health Security (JIHS). The NCBN primarily collects samples from patients with various diseases, amassing a total of more than 250,000 participants and 800,000 human biospecimens as of the end of March 2026. The primary sample types are blood and DNA, with spinal fluid and frozen tissue samples also collected depending on the characteristics of the disease. These samples are accompanied by highly specialized and traceable clinical information supported by advanced medical care and expertise. Moreover, some samples are accompanied by whole-genome sequencing data. Consequently, these resources provide a unique platform for translational research, biomarker discovery, and genomic medicine in Japan. In the present review, we provide a detailed account of the recent achievements of NCBN biobanks and their biospecimens and genomic data.
SN - 1664-8021
ER -